Keywords: Abbott, Solvay, Mergers and acquisitions, Nycomed, UCB, Takeda
Abbott to buy Solvay pharmaceuticals business for 4.5 billion euros, but will bidding war cease?
Article | 28 September 2009
US health care giant Abbott Laboratories has reached a definitive agreement with the Solvay Group for Abbott to acquire Belgium-based ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- Is failure to adopt business process management putting the pharma industry at risk?
- AstraZeneca's naloxegol meets endpoints; EMA validates Gilead's sofosbuvir MAA
- Ignyta acquires Actagene Oncology and entry into cancer personalized medicine
- Sanofi and Regeneron's dupilumab shows 87% reduction in risk of asthma exacerbations
- Boehringer Ingelheim gets FDA warning letter on cGMP failures
